查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1639368

實驗室化學品 -市場佔有率分析、產業趨勢/統計、成長預測 (2025-2030)

Laboratory Chemicals - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

實驗室化學品市場規模預計到 2025 年為 288.7 億美元，預計到 2030 年將達到 356.3 億美元，預測期內（2025-2030 年）複合年成長率為 4.3%。

實驗室化學品-市場-IMG1

COVID-19的爆發對2020年的市場產生了負面影響。然而，市場已達到疫情前的水平，預計在預測期內將穩定成長。

主要亮點

  • 實驗室化學品市場受到生物和化學科學領域研發活動活性化以及污水處理用途增加的推動。
  • 然而，實驗室化學品替代品的可用性可能會阻礙市場成長。
  • 細胞培養、重組 DNA、生物療法和奈米材料開發等技術的進步預計將在未來提供市場機會。
  • 由於研發活動的活性化，預計歐洲將主導市場。

實驗室化學品市場趨勢

工業應用證實了更高的成長潛力

  • 實驗室化學品廣泛用於各種工業製程，從溴化到許多低溫反應。
  • 最常見的實驗室化學過程包括醯氯製備、羧基化、離子交換反應、硝化、Suzuki 偶聯和 Williamson 醚合成。
  • 這些化學物質對於透過結晶和蒸餾過程生產各種商業產品至關重要。
  • 農業產量的增加正在推動全球市場對硫酸的需求。到 2026 年，最不開發中國家的卡路里供應量預計將達到平均每天 2,450 大卡，其他開發中國家則將達到每天 3,000 大卡以上。預計這將增加全球市場對農產品的需求，進而增加對農業研究的需求，進而推動化學製造中對實驗室化學品的需求。
  • 目前，美國擁有全球最大的醫療設備產業。根據美國商務部國際貿易管理局（ITA）的SelectUSA計劃，該國的醫療設備醫療設備是全球最大的，價值1,560億美元，預計到2023年將達到2,080億美元。
  • 根據美國精算師辦公室（CMS）發布的資料，預計醫療保健支出在預測期內將大幅增加。
  • 勞動和工業安全以及事故預防也導致研發部門增加投資，以開發更永續、對環境危害更小的新化學品。
  • 因此，工業部門需求的增加預計將增加對實驗室化學品的需求。

預計歐洲將主導市場

  • 多年來，義大利工業發生了巨大變化，更加面向國際市場，競爭力也更強。
  • 義大利擁有世界上最大的化學品市場之一。該國的化學品銷售額在歐盟 (EU) 中排名第三，佔該地區化學品銷售額的 11% 以上。義大利不僅是主要的化學品生產國，也是主要的國際化學品出口國。
  • 義大利主要集中在中高科技領域（醫藥、機械、工業等）。即使在傳統領域，義大利工業也堅定地致力於創新，專利申請數量的迅速增加就證明了這一點。
  • 近年來，義大利製藥業在生產、投資和貿易方面均取得了顯著成長。 CDMO（委外研發機構）是義大利製藥業的主要結構，透過將生產步驟委託給第三方設施來發揮作用，從而實現產量的高速成長。
  • 德國製藥市場被世界領先的製藥公司視為一個有前途的子部門，這些公司正在向德國擴張，以鞏固其在全球市場的地位。例如
  • 2022 年 8 月，全球製藥公司拜耳將投資 2.8698 億美元在德國勒沃庫森開發其 Solida-1 製藥廠。該設施預計將於 2024 年運作，將致力於生產癌症和心血管疾病的治療藥物。
  • 愛爾蘭是領先的製藥中心，佔世界藥品產量的 5% 以上。愛爾蘭製藥業多年來的發展以全球最大的九家製藥公司的存在為標誌，其中愛爾蘭生產了世界十大最暢銷藥品中的七種。此外，過去十年，製藥業也受惠於約 80 億美元的新設施投資。
  • 義大利擁有 5,000 多家製藥公司，其中包括 Menarini、Chiesi、Angelini、Bracco、Recordati 和 Alpha Sigma 等主要企業。為了因應市場需求的逐步持續成長，這些企業在過去的十年中一直保持著產值的持續成長。
  • 義大利製造業在稅收優惠的支持下，已開始維修各種生產工廠，特別是工業4.0技術方面。
  • 預計此類發展將增加預測期內對實驗室化學品的需求。

實驗室化學品行業概況

據估計，實驗室化學品市場將部分分為全球參與企業和本地參與者。實驗室化學品市場公認的主要企業包括（排名不分先後）ITW Reagents Division、Merck KGaA、Beckman Coulter Inc.、General Electric 和 Avantor Inc.。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 3 個月分析師支持

目錄

第1章簡介

  • 調查先決條件
  • 調查範圍

第2章調查方法

第3章執行摘要

第4章市場動態

  • 促進因素
    • 擴大生化領域的研發活動
    • 增加污水處理中的使用
    • 其他司機
  • 抑制因素
    • 實驗室化學品替代品的可用性
    • 其他限制因素
  • 產業價值鏈分析
  • 波特五力分析
    • 供應商的議價能力
    • 消費者議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭程度

第5章市場區隔（以金額為準的市場規模）

  • 類型
    • 分子生物學
    • 細胞激素/趨化素測試
    • 聚醣分析
    • 免疫化學
    • 細胞/組織培養
    • 環保檢驗
    • 生物化學
    • 其他
  • 目的
    • 工業的
    • 學術/教育
    • 政府機構
    • 醫療（製藥）
  • 地區
    • 亞太地區
      • 中國
      • 印度
      • 日本
      • 韓國
      • 其他亞太地區
    • 北美洲
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 義大利
      • 法國
      • 西班牙
      • 歐洲其他地區
    • 南美洲
      • 巴西
      • 阿根廷
      • 南美洲其他地區
    • 中東/非洲
      • 沙烏地阿拉伯
      • 南非
      • 其他中東/非洲

第6章 競爭狀況

  • 併購、合資、聯盟、協議
  • 市場佔有率(%)**/排名分析
  • 主要企業策略
  • 公司簡介
    • Avantor Inc.
    • BD BioScience
    • Beckman Coulter Inc.
    • BiosYnth SRL
    • Carlo Erba Reagents SRL
    • GE Healthcare
    • ITW Reagents Division
    • Merck KGaA
    • Meridian Life Science Inc.
    • Mitsubishi Rayon Co. Ltd
    • Morphisto GmbH
    • PerkinElmer Inc.
    • R&D Systems
    • Sigma-Aldrich Corp.
    • UJIFILM Wako Chemicals

第7章 市場機會及未來趨勢

  • 細胞培養、重組 DNA 和生物治療等技術的進步
  • 活性化奈米材料開發研究活動
簡介目錄
Product Code: 48894

The Laboratory Chemicals Market size is estimated at USD 28.87 billion in 2025, and is expected to reach USD 35.63 billion by 2030, at a CAGR of 4.3% during the forecast period (2025-2030).

Laboratory Chemicals - Market - IMG1

The COVID-19 outbreak negatively impacted the market in 2020. However, the market has since reached pre-pandemic levels and is expected to grow steadily during the forecast period.

Key Highlights

  • The laboratory chemicals market is driven by growing R&D activities in the field of biological and chemical sciences and increasing usage in wastewater treatment.
  • However, the availability of substitutes for laboratory chemicals is likely to hinder the market's growth.
  • Advancements in technologies, such as cell culture, recombinant DNA, and biotherapeutics, and the development of nanomaterials are projected to act as an opportunity for the market in the future.
  • Due to increasing research and development activities, Europe region is expected to dominate the market.

Laboratory Chemicals Market Trends

Industrial Application to Witness the Higher Potential Growth

  • Laboratory chemicals are extensively used in various industrial processes, ranging from bromination to numerous cryogenic reactions.
  • Some of the most common laboratory chemical processes include acid chloride preparations, carboxylation, ion-exchange reactions, nitration, Suzuki coupling, and Williamson's ether synthesis.
  • These chemicals are essential to manufacture various commercial products in re-crystallization and distillation processes.
  • Increasing agricultural output is boosting the demand for sulphuric acid in the global market. By 2026, calorie availability is projected to reach 2,450 kcal on average in least-developed countries and exceed 3,000 kcal per day in other developing countries. This is expected to increase the demand for crops in the global market, which, in turn, may increase the demand for agricultural research, thus, driving up the need for laboratory chemicals in chemical manufacturing.
  • Currently, the United States is the largest medical device industry in the world. According to SelectUSA, a program by The International Trade Administration (ITA), US Department of Commerce, the medical devices market in the country is the largest medical devices market in the world, which is valued at USD 156 billion and is estimated to reach USD 208 billion by 2023.
  • As per data published by the United States; CMS (Office of the Actuary), healthcare expenditure is expected to increase significantly during the forecast period.
  • Occupational and industrial safety and disaster prevention have led to increasing investments in the R&D department to formulate new chemicals that are equally sustainable and less hazardous to the environment.
  • Hence, growing demand from the industrial sector is expected to increase the demand for laboratory chemicals.

Europe Region is Expected to Dominate the Market

  • The Italian industry has changed significantly over the years, orienting itself toward international markets and strengthening its competitiveness.
  • Italy has one of the world's largest chemical marketplaces. The country has the third-largest chemical revenue in the European Union, accounting for above 11% of regional chemical sales. Aside from being a major chemical producer, Italy is also a major chemical exporter internationally.
  • Its focus has been mainly on medium to high-technology sectors (such as pharmaceuticals, mechanics, and the chemical industry). Even in the traditional sectors, the Italian industry focused on strong innovation, as evidenced by the sharp increase in patent applications.
  • The Italian pharmaceutical industry has grown considerably in production, investments, and trade over recent years. CDMO (Contract Development Manufacturing Organization) is the main structure of the Italian pharmaceutical industry, which functions by outsourcing production stages to third-party facilities, thereby enabling high production growth.
  • The pharmaceutical market in Germany is identified as a top-prospect sub-sector by world-leading pharmaceutical manufacturing companies, which are expanding into the country to strengthen their position in the global market. For instance,
  • In August 2022, the critical global pharmaceutical player, Bayer, is undergoing the development of the Solida-1 pharmaceutical production facility at its site in Leverkusen in, Germany, for an investment of USD 286.98 million. The facility, which is expected to come on stream in 2024, shall be dedicated to producing drugs for treating cancer and cardiovascular diseases.
  • Ireland is a prominent pharmaceutical location contributing to more than 5% of global pharmaceutical production. The growth in Ireland's pharmaceutical sector over the years is marked by the presence of 9 of the world's largest pharmaceutical companies, enabling the country to produce 7 of the top 10 selling drugs globally. Further, the sector has benefitted from around USD 8 billion investment in setting up new facilities over the 10 years.
  • Italy boasts over 5,000 pharmaceutical companies, with top players including Menarini, Chiesi, Angelini, Bracco, Recordati, and Alfasigma, among others. Responding to the gradual and continuous rise in market demand, these companies have maintained continued growth in production value through the last decade.
  • The Italian manufacturing sector has started renovating various production plants, particularly concerning Industry 4.0 technologies, supported by tax incentives.
  • All such developments are expected to boost the demand for laboratory chemicals during the forecast period.

Laboratory Chemicals Industry Overview

The laboratory chemicals market is estimated to be partially fragmented, with the presence of global and local players. Major recognized players in the laboratory chemicals market (not in any particular order) include ITW Reagents Division, Merck KGaA, Beckman Coulter Inc., General Electric, and Avantor Inc.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Drivers
    • 4.1.1 Growing R&D Activities in the Field of Biological and Chemical Sciences
    • 4.1.2 Increasing Usage in Wastewater Treatment
    • 4.1.3 Other Drivers
  • 4.2 Restraints
    • 4.2.1 Availability of Substitutes for Laboratory Chemicals
    • 4.2.2 Other Restraints
  • 4.3 Industry Value Chain Analysis
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Degree of Competition

5 MARKET SEGMENTATION (Market Size in Value)

  • 5.1 Type
    • 5.1.1 Molecular Biology
    • 5.1.2 Cytokine and Chemokine Testing
    • 5.1.3 Carbohydrate Analysis
    • 5.1.4 Immunochemistry
    • 5.1.5 Cell/Tissue Culture
    • 5.1.6 Environmental Testing
    • 5.1.7 Biochemistry
    • 5.1.8 Other Types
  • 5.2 Application
    • 5.2.1 Industrial
    • 5.2.2 Academia/Educational
    • 5.2.3 Government
    • 5.2.4 Healthcare (Pharmaceutical)
  • 5.3 Geography
    • 5.3.1 Asia-Pacific
      • 5.3.1.1 China
      • 5.3.1.2 India
      • 5.3.1.3 Japan
      • 5.3.1.4 South Korea
      • 5.3.1.5 Rest of Asia-Pacific
    • 5.3.2 North America
      • 5.3.2.1 United States
      • 5.3.2.2 Canada
      • 5.3.2.3 Mexico
    • 5.3.3 Europe
      • 5.3.3.1 Germany
      • 5.3.3.2 United Kingdom
      • 5.3.3.3 Italy
      • 5.3.3.4 France
      • 5.3.3.5 Spain
      • 5.3.3.6 Rest of Europe
    • 5.3.4 South America
      • 5.3.4.1 Brazil
      • 5.3.4.2 Argentina
      • 5.3.4.3 Rest of South America
    • 5.3.5 Middle-East and Africa
      • 5.3.5.1 Saudi Arabia
      • 5.3.5.2 South Africa
      • 5.3.5.3 Rest of Middle-East and Africa

6 COMPETITIVE LANDSCAPE

  • 6.1 Mergers and Acquisitions, Joint Ventures, Collaborations, and Agreements
  • 6.2 Market Share(%)**/Ranking Analysis
  • 6.3 Strategies Adopted by Leading Players
  • 6.4 Company Profiles
    • 6.4.1 Avantor Inc.
    • 6.4.2 BD BioScience
    • 6.4.3 Beckman Coulter Inc.
    • 6.4.4 BiosYnth SRL
    • 6.4.5 Carlo Erba Reagents SRL
    • 6.4.6 GE Healthcare
    • 6.4.7 ITW Reagents Division
    • 6.4.8 Merck KGaA
    • 6.4.9 Meridian Life Science Inc.
    • 6.4.10 Mitsubishi Rayon Co. Ltd
    • 6.4.11 Morphisto GmbH
    • 6.4.12 PerkinElmer Inc.
    • 6.4.13 R&D Systems
    • 6.4.14 Sigma-Aldrich Corp.
    • 6.4.15 UJIFILM Wako Chemicals

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

  • 7.1 Advancement in Technologies, such as Cell Culture, Recombinant DNA, and Biotherapeutics
  • 7.2 Increasing Research Activities for Development of Nanomaterials